Sanofi launches AI-powered agent for sales representatives
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
Approved as a web-based pre-diagnostic tool for suspected rare diseases and classified as a Class A (non-sterile and non-measuring) medical device
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
He brings extensive cross-functional expertise built through leadership roles
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
Subscribe To Our Newsletter & Stay Updated